Cardiac Safety Annual Business Meeting

The HESI Cardiac Safety Committee will convene their annual business meeting on 6 April 2023. The mission of the HESI Cardiac Safety Committee is to improve public health by reducing unanticipated cardiovascular-related adverse effects from drugs or chemicals, and to develop innovative approaches to support early detection and prediction as well as improved understanding of cardiovascular toxicology and pathobiology.

The meeting will feature updates from each of the main Committee Working Groups as well as a keynote speaker on new approach methodologies from two different perspectives in drug development and regulatory spaces. Participants will also have an opportunity to engage in discussions around current and potential future projects.

Learn more about the Cardiac Safety Committee by visiting their webpage or contact Ms. Jennifer Pierson (jpierson@hesiglobal.org).